FINWIRES · TerminalLIVE
FINWIRES

JFrog Poised to See Another 'Solid' Quarter With Steady Artifactory Use, Oppenheimer Says

By

JFrog (FROG) is expected to see another "solid" quarter aided by a steady Artifactory consumption, growing Curation adoption, and minimal operational disruption from the Iran conflict, Oppenheimer said in a note Thursday.

The brokerage said it expects a 2% to 4% Q1 revenue upside to consensus estimate of $147.5 million, while the company's $300 million share repurchase program will see limited activity on account of the 30-day creditor objection period per Israeli regulation.

Recent artificial intelligence-driven concerns related to the stock are "overly bearish," analysts said, adding that they continue to view AI as a strong 2026 Artifactory consumption driver for core enterprise expansion.

JFrog hasn't experienced material operational impact from the Iran conflict and, if needed, has contingency plans in place, like relocation management and shifting R&D activity to other regions, according to the note.

The company is scheduled to report its Q1 financial results on May 7.

Oppenheimer has an outperform rating on the stock, and lowered its price target to $63 from $75.

Shares of JFrog were down 6.5% in Thursday trading.

Price: $43.78, Change: $-3.03, Percent Change: -6.47%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS